Showing results 1 to 2 of 2
Issue Date | Title | Author(s) | Type |
---|---|---|---|
2016 | INFLIXIMAB AS THE FIRST RETREATMENT IN PATIENTS WITH KAWASAKI DISEASE RESISTANT TO INITIAL INTRAVENOUS IMMUNOGLOBULIN | 홍영미; 손세정 | Article |
2020 | Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries? | 배승진 | Article |